Christopher Sorli
Chief Tech/Sci/R&D Officer chez ACERUS PHARMACEUTICALS CORPORATION
Profil
Christopher Sorli is currently the Chief Medical Officer at Acerus Pharmaceuticals Corp.
Prior to this, he worked at Sanofi SA from 2016 to 2020, where he held the position of VP-Medical Affairs & Head-Cardio Metabolic Disease from 2019 to 2020.
Postes actifs de Christopher Sorli
| Sociétés | Poste | Début |
|---|---|---|
| ACERUS PHARMACEUTICALS CORPORATION | Chief Tech/Sci/R&D Officer | 17/07/2020 |
Anciens postes connus de Christopher Sorli
| Sociétés | Poste | Fin |
|---|---|---|
| Sanofi SA | Corporate Officer/Principal | 01/07/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| Sanofi SA | Health Technology |
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
